Identification of epigenetically silenced genes in tumor endothelial cells

Debby M E I Hellebrekers, Veerle Melotte, Emmanuelle Viré, Elise Langenkamp, Grietje Molema, François Fuks, James G. Herman, Wim Van Criekinge, Arjan W. Griffioen, Manon Van Engeland

Research output: Contribution to journalArticle

Abstract

Tumor angiogenesis requires intricate regulation of gene expression in endothelial cells. We recently showed that DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors directly repress endothelial cell growth and tumor angiogenesis, suggesting that epigenetic modifications mediated by DNMTs and HDAC are involved in regulation of endothelial cell gene expression during tumor angiogenesis. To understand the mechanisms behind the epigenetic regulation of tumor angiogenesis, we used microarray analysis to perform a comprehensive screen to identify genes down-regulated in tumor-conditioned versus quiescent endothelial cells, and reexpressed by 5-aza-2′- deoxycytidine (DAC) and trichostatin A (TSA). Among the 81 genes identified, 77% harbored a promoter CpG island. Validation of mRNA levels of a subset of genes confirmed significant down-regulation in tumor-conditioned endothelial cells and reactivation by treatment with a combination of DAC and TSA, as well as by both compounds separately. Silencing of these genes in tumor-conditioned endothelial cells correlated with promoter histone H3 deacetylation and loss of H3 lysine 4 methylation, but did not involve DNA methylation of promoter CpG islands. For six genes, down-regulation in microdissected human tumor endothelium was confirmed. Functional validation by RNA interference revealed that clusterin, fibrillin 1, and quiescin Q6 are negative regulators of endothelial cell growth and angiogenesis. In summary, our data identify novel angiogenesis-suppressing genes that become silenced in tumor-conditioned endothelial cells in association with promoter histone modifications and reactivated by DNMT and HDAC inhibitors through reversal of these epigenetic modifications, providing a mechanism for epigenetic regulation of tumor angiogenesis.

Original languageEnglish (US)
Pages (from-to)4138-4148
Number of pages11
JournalCancer Research
Volume67
Issue number9
DOIs
StatePublished - May 1 2007

Fingerprint

Endothelial Cells
Genes
Neoplasms
Epigenomics
trichostatin A
CpG Islands
Histone Deacetylase Inhibitors
decitabine
Methyltransferases
Down-Regulation
Histone Code
Clusterin
Histone Deacetylases
DNA
Gene Expression Regulation
Gene Silencing
DNA Methylation
Microarray Analysis
Growth
RNA Interference

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hellebrekers, D. M. E. I., Melotte, V., Viré, E., Langenkamp, E., Molema, G., Fuks, F., ... Van Engeland, M. (2007). Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Research, 67(9), 4138-4148. https://doi.org/10.1158/0008-5472.CAN-06-3032

Identification of epigenetically silenced genes in tumor endothelial cells. / Hellebrekers, Debby M E I; Melotte, Veerle; Viré, Emmanuelle; Langenkamp, Elise; Molema, Grietje; Fuks, François; Herman, James G.; Van Criekinge, Wim; Griffioen, Arjan W.; Van Engeland, Manon.

In: Cancer Research, Vol. 67, No. 9, 01.05.2007, p. 4138-4148.

Research output: Contribution to journalArticle

Hellebrekers, DMEI, Melotte, V, Viré, E, Langenkamp, E, Molema, G, Fuks, F, Herman, JG, Van Criekinge, W, Griffioen, AW & Van Engeland, M 2007, 'Identification of epigenetically silenced genes in tumor endothelial cells', Cancer Research, vol. 67, no. 9, pp. 4138-4148. https://doi.org/10.1158/0008-5472.CAN-06-3032
Hellebrekers DMEI, Melotte V, Viré E, Langenkamp E, Molema G, Fuks F et al. Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Research. 2007 May 1;67(9):4138-4148. https://doi.org/10.1158/0008-5472.CAN-06-3032
Hellebrekers, Debby M E I ; Melotte, Veerle ; Viré, Emmanuelle ; Langenkamp, Elise ; Molema, Grietje ; Fuks, François ; Herman, James G. ; Van Criekinge, Wim ; Griffioen, Arjan W. ; Van Engeland, Manon. / Identification of epigenetically silenced genes in tumor endothelial cells. In: Cancer Research. 2007 ; Vol. 67, No. 9. pp. 4138-4148.
@article{8dcf01a27c9d4801a7a922365e3d7337,
title = "Identification of epigenetically silenced genes in tumor endothelial cells",
abstract = "Tumor angiogenesis requires intricate regulation of gene expression in endothelial cells. We recently showed that DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors directly repress endothelial cell growth and tumor angiogenesis, suggesting that epigenetic modifications mediated by DNMTs and HDAC are involved in regulation of endothelial cell gene expression during tumor angiogenesis. To understand the mechanisms behind the epigenetic regulation of tumor angiogenesis, we used microarray analysis to perform a comprehensive screen to identify genes down-regulated in tumor-conditioned versus quiescent endothelial cells, and reexpressed by 5-aza-2′- deoxycytidine (DAC) and trichostatin A (TSA). Among the 81 genes identified, 77{\%} harbored a promoter CpG island. Validation of mRNA levels of a subset of genes confirmed significant down-regulation in tumor-conditioned endothelial cells and reactivation by treatment with a combination of DAC and TSA, as well as by both compounds separately. Silencing of these genes in tumor-conditioned endothelial cells correlated with promoter histone H3 deacetylation and loss of H3 lysine 4 methylation, but did not involve DNA methylation of promoter CpG islands. For six genes, down-regulation in microdissected human tumor endothelium was confirmed. Functional validation by RNA interference revealed that clusterin, fibrillin 1, and quiescin Q6 are negative regulators of endothelial cell growth and angiogenesis. In summary, our data identify novel angiogenesis-suppressing genes that become silenced in tumor-conditioned endothelial cells in association with promoter histone modifications and reactivated by DNMT and HDAC inhibitors through reversal of these epigenetic modifications, providing a mechanism for epigenetic regulation of tumor angiogenesis.",
author = "Hellebrekers, {Debby M E I} and Veerle Melotte and Emmanuelle Vir{\'e} and Elise Langenkamp and Grietje Molema and Fran{\cc}ois Fuks and Herman, {James G.} and {Van Criekinge}, Wim and Griffioen, {Arjan W.} and {Van Engeland}, Manon",
year = "2007",
month = "5",
day = "1",
doi = "10.1158/0008-5472.CAN-06-3032",
language = "English (US)",
volume = "67",
pages = "4138--4148",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Identification of epigenetically silenced genes in tumor endothelial cells

AU - Hellebrekers, Debby M E I

AU - Melotte, Veerle

AU - Viré, Emmanuelle

AU - Langenkamp, Elise

AU - Molema, Grietje

AU - Fuks, François

AU - Herman, James G.

AU - Van Criekinge, Wim

AU - Griffioen, Arjan W.

AU - Van Engeland, Manon

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Tumor angiogenesis requires intricate regulation of gene expression in endothelial cells. We recently showed that DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors directly repress endothelial cell growth and tumor angiogenesis, suggesting that epigenetic modifications mediated by DNMTs and HDAC are involved in regulation of endothelial cell gene expression during tumor angiogenesis. To understand the mechanisms behind the epigenetic regulation of tumor angiogenesis, we used microarray analysis to perform a comprehensive screen to identify genes down-regulated in tumor-conditioned versus quiescent endothelial cells, and reexpressed by 5-aza-2′- deoxycytidine (DAC) and trichostatin A (TSA). Among the 81 genes identified, 77% harbored a promoter CpG island. Validation of mRNA levels of a subset of genes confirmed significant down-regulation in tumor-conditioned endothelial cells and reactivation by treatment with a combination of DAC and TSA, as well as by both compounds separately. Silencing of these genes in tumor-conditioned endothelial cells correlated with promoter histone H3 deacetylation and loss of H3 lysine 4 methylation, but did not involve DNA methylation of promoter CpG islands. For six genes, down-regulation in microdissected human tumor endothelium was confirmed. Functional validation by RNA interference revealed that clusterin, fibrillin 1, and quiescin Q6 are negative regulators of endothelial cell growth and angiogenesis. In summary, our data identify novel angiogenesis-suppressing genes that become silenced in tumor-conditioned endothelial cells in association with promoter histone modifications and reactivated by DNMT and HDAC inhibitors through reversal of these epigenetic modifications, providing a mechanism for epigenetic regulation of tumor angiogenesis.

AB - Tumor angiogenesis requires intricate regulation of gene expression in endothelial cells. We recently showed that DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors directly repress endothelial cell growth and tumor angiogenesis, suggesting that epigenetic modifications mediated by DNMTs and HDAC are involved in regulation of endothelial cell gene expression during tumor angiogenesis. To understand the mechanisms behind the epigenetic regulation of tumor angiogenesis, we used microarray analysis to perform a comprehensive screen to identify genes down-regulated in tumor-conditioned versus quiescent endothelial cells, and reexpressed by 5-aza-2′- deoxycytidine (DAC) and trichostatin A (TSA). Among the 81 genes identified, 77% harbored a promoter CpG island. Validation of mRNA levels of a subset of genes confirmed significant down-regulation in tumor-conditioned endothelial cells and reactivation by treatment with a combination of DAC and TSA, as well as by both compounds separately. Silencing of these genes in tumor-conditioned endothelial cells correlated with promoter histone H3 deacetylation and loss of H3 lysine 4 methylation, but did not involve DNA methylation of promoter CpG islands. For six genes, down-regulation in microdissected human tumor endothelium was confirmed. Functional validation by RNA interference revealed that clusterin, fibrillin 1, and quiescin Q6 are negative regulators of endothelial cell growth and angiogenesis. In summary, our data identify novel angiogenesis-suppressing genes that become silenced in tumor-conditioned endothelial cells in association with promoter histone modifications and reactivated by DNMT and HDAC inhibitors through reversal of these epigenetic modifications, providing a mechanism for epigenetic regulation of tumor angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=34249323034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249323034&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-3032

DO - 10.1158/0008-5472.CAN-06-3032

M3 - Article

C2 - 17483324

AN - SCOPUS:34249323034

VL - 67

SP - 4138

EP - 4148

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 9

ER -